Teva Pharmaceutical Industries Limited Sponsored ADR(NYSE : TEVA)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Generic
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AGN | Allergan plc | 0.33% | 189.51 | 2.8% | $351.31m | |
| TEVA | Teva Pharmaceutical Industries Limited Sponsored ADR | 0.85% | 21.45 | 2.1% | $248.26m | |
| ZTS | Zoetis, Inc. Class A | -0.36% | 91.50 | 1.9% | $197.97m | |
| MYL | Mylan N.V. | -0.65% | 32.21 | 3.2% | $168.85m | |
| TXMD | TherapeuticsMD, Inc. | -1.44% | 5.48 | 25.8% | $15.73m | |
| RDY | Dr. Reddy's Laboratories Ltd. Sponsored ADR | 1.67% | 34.72 | 2.0% | $9.43m | |
| ABEO | Abeona Therapeutics, Inc. | -3.81% | 9.34 | 7.9% | $6.69m | |
| TARO | Taro Pharmaceutical Industries Ltd. | 0.99% | 95.31 | 6.3% | $4.53m | |
| KIN | Kindred Biosciences, Inc. | -1.45% | 12.88 | 0.3% | $3.16m | |
| JAGX | Jaguar Animal Health, Inc. | 0.93% | 0.55 | 9.8% | $2.70m | |
| PETX | Aratana Therapeutics, Inc. | -0.74% | 5.36 | 8.7% | $1.47m | |
| LFVN | LifeVantage Corporation | -1.15% | 10.28 | 3.3% | $1.19m | |
| CPHI | China Pharma Holdings, Inc. | -4.44% | 0.43 | 0.1% | $0.77m |
Company Profile
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.